目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T11426 | FXR | ||
Gly-β-MCA 是一种具有口服生物活性、肠道选择性和有效的法尼酯X受体 (FXR) 抑制剂,是一种胆汁酸,可用于研究肥胖和糖尿病。 | |||
T63042 | FXR | ||
NDB 是一种具有选择性和有效性的 hFXRα 拮抗剂,可抑制原代小鼠肝细胞中 GW4064 刺激的 FXR/RXR 相互作用和 FXRα 靶基因表达。NDB可用于研究糖尿病。 | |||
T8818 | GPCR19 | ||
TC-G 1005 是具有口服活性的TGR5选择性激动剂,能够激活 hTGR5 (EC50:0.72 nM)和 mTGR5 (EC50:6.2 nM)。它能够减少小鼠体内葡萄糖水平。 | |||
T12583 | Others | ||
PX20606 trans racemate is an agonist of FXR (EC50s of 32 and 34 nM for FXR in FRET and M1H assay, respectively). | |||
T13093 | FXR | ||
Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM). | |||
T25417 | |||
Fexarene is a non-steroidal FXR agonist. | |||
T69724 | |||
Cilofexor, also known as GS-9674, is a farnesoid X receptor (FXR) agonist. The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC. In clinical study, cilofexor was well tolerated and led to significant improvements in liver biochemistries and markers of cholestasis in patients with PSC. | |||
T68612 | |||
DM175 is a novel partial FXR agonist, causing specific modulatory effects on FXR activity that clearly differ from classical FXR agonists. | |||
T73414 | |||
EDP-305是一种具有选择性的口服farnesoid X受体(FXR)激动剂,其EC50值分别为34 nM(CHO细胞嵌合性FXR)和8 nM(HEK细胞全长FXR)。该化合物展现了强大且持久的抗纤维化效果,并适用于原发性胆道胆管炎(PBC)与非酒精性脂肪性肝炎(NASH)的研究。 | |||
T24837 | |||
ST-1892 is a soluble partial FXR agonist. |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-06768 | NR1H4 Protein, Human, Recombinant (His) | Human | E. coli | ||
NR1H4 Protein, Human, Recombinant (His) is expressed in E. coli with His tag. The predicted molecular weight is 27.83 kDa. Accession number: Q96RI1-1
|
|||||
TMPY-06756 | NR1H4 Protein, Mouse, Recombinant (His) | Mouse | E. coli | ||
NR1H4 Protein, Mouse, Recombinant (His) is expressed in E. coli with His tag. The predicted molecular weight is 27.80 kDa.
|
|||||
TMPH-01355 | FXR1 Protein, Human, Recombinant (His) | Human | E. coli | ||
RNA-binding protein required for embryonic and postnatal development of muscle tissue. May regulate intracellular transport and local translation of certain mRNAs.
|
|||||
TMPY-02987 | Vitamin D Receptor/VDR Protein, Mouse, Recombinant (His) | Mouse | Baculovirus-Insect Cells | ||
VDR (vitamin D (1,25- dihydroxyvitamin D3) receptor), also known as NR1I1, belongs to the NR1I family, NR1 subfamily. It is composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. Vitamin D receptors (VDRs) are members of the NR1I family, which also includes pregnane X (PXR) and constitutive androstane (CAR) receptors, that form heterodimers with members of the retinoid X receptor family. VDRs repress expression of 1alpha-hydroxylase (the proximal activator of 1,25(OH)2D3) and induce expression of the 1,25(OH)2D3 inactivating enzyme CYP24. Also, it has recently been identified as an additional bile acid receptor alongside FXR and may function to protect gut against the toxic and carcinogenic effects of these endobiotics. VDR is expressed in the intestine, thyroid and kidney and has a vital role in calcium homeostasis. It is the nuclear hormone receptor, also called transcription factor that mediates the action of vitamin D3. Inherited mutations in the VDR gene leads to rickets.
|
|||||
TMPY-02706 | Vitamin D Receptor/VDR Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells | ||
VDR (vitamin D (1,25- dihydroxyvitamin D3) receptor), also known as NR1I1, belongs to the NR1I family, NR1 subfamily. It is composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. Vitamin D receptors (VDRs) are members of the NR1I family, which also includes pregnane X (PXR) and constitutive androstane (CAR) receptors, that form heterodimers with members of the retinoid X receptor family. VDRs repress expression of 1alpha-hydroxylase (the proximal activator of 1,25(OH)2D3) and induce expression of the 1,25(OH)2D3 inactivating enzyme CYP24. Also, it has recently been identified as an additional bile acid receptor alongside FXR and may function to protect gut against the toxic and carcinogenic effects of these endobiotics. VDR is expressed in the intestine, thyroid and kidney and has a vital role in calcium homeostasis. It is the nuclear hormone receptor, also called transcription factor that mediates the action of vitamin D3. Inherited mutations in the VDR gene leads to rickets.
|